July 12, 2013
Mayo Clinic in the News Weekly Highlights
July 12 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Philadelphia Enquirer […]
Tags: ABC News, ABC News Nightline, ABCnews.com, acid reflux, alzheimer's disease, and Blood Institute, antibiotics, antidepressants, Arizona Republic, Australian News, bio-plotter, biomedical corridor
September 14, 2012
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations CNN How to indulge […]
Tags: Alzheimer's drug, bapineuzumab, BodyGuardian, Choline C 11, CNN, doctor burnout, Dr Charles Bruce, Dr. Donald Hensrud, Dr. Ed Creagan, Dr. Fred Kusumoto, Dr. Issam Moussa, Dr. Leslie Sim
August 2, 2012
Blood Cancer Drug Effective in Treating Kidney, Breast Cancer
Two drugs approved by the Food and Drug Administration for blood cancer treatment may also be used to treat triple negative breast and kidney cancer, researchers say. The drugs are romidepsin and decitabine. Together they can activate a gene sFRP1 (secreted frizzled related protein one) that can stop the growth of cancer cells. “We now […]
Tags: decitabine, Dr. John Copland, FDA, Medical Daily, romidepsin
July 26, 2012
Group Asks FDA to Provide Clearer Painkiller Guidelines
A group of pain experts and health officials are asking the Food and Drug Administration to provide clearer guidance to physicians on how to use extended-release painkillers and to limit claims pharmaceutical companies can make about the high-dosage medications. If approved, drug companies would be blocked from marketing their powerful painkillers as remedies for more […]
Tags: citizen's petition, extended-release painkillers, FDA, Wall Street Journal
February 9, 2012
FDA panel votes against Xgeva for prostate cancer
panel of cancer experts voted against a new use for Amgen’s Xgeva in prostate cancer on Wednesday, saying the drug’s ability to slow the spread of the disease did not translate into meaningful benefits for patients.The Food and Drug Administration’s cancer drug panel voted 12-1 that the benefits of the drug did not outweigh its […]
Tags: amgen, cancer drug panel, Dr. Ronald Richardson, FDA, Food and Drug Administration, prostate cancer, Xgeva
February 7, 2012
Tendon injury treatment firm with Mayo Clinic ties lands $11.8 million
A tendon injury treatment firm that has licensed technology developed at the Mayo Clinic has raised $11.8 million through a PIPE (private investment in a public entity) transaction. Tenex Health is a California company that has developed the FAST (Focused Aspiration of Soft Tissue) procedure for percutaneous removal of tissue that can help restore the […]
Tags: FAST, FDA, Focused Aspiration of Soft Tissue, PIPE, private investment in a public entity, soft tissue, tendons, Tenex Health
January 24, 2012
Mayo Clinic-linked med device firm close to FDA OK
Here’s a little from an interesting piece by Lindsay Patton on Dailyrx.com about Torax Medical’s anti-acid reflux device. Mayo Clinic helped launch Torax in 2003 and Mayo Medical Ventures has invested in the company in the past…FDA panel has given unanimous support to LINX, an implantable device to treat chronic and severe acid reflux. That […]
Tags: acid reflux, FDA, LINX, Mayo Medical Ventures, Torax Medical